IL211149D0

Two phase bioactive formulations

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

13 members in 5 offices

This recordMember, by publication datePriority claim

Priority claims6

Priority claims
Document	Office	Kind	Date
19240008	United States of America	A	2008-08-15
2009052457	United States of America	W	2009-07-31
12192400	–	–	–
PCTUS2009052457	–	–	–
US20080192400	–	–	–
WO2009US52457	–	–	–

Members13

Family members, oldest first
Document	Office	Kind
CA2734119A1	Canada	A1	2010-02-18
US2010040692A1	United States of America	A1	2010-02-18
WO2010019398A1	World Intellectual Property Organization (WIPO)	A1	2010-02-18
IL211149A0	Israel	A0	2011-04-28
IL211149D0This record	Israel	D0	2011-04-28
EP2323984A1	European Patent Office (EPO)	A1	2011-05-25
EP2323984A4	European Patent Office (EPO)	A4	2011-11-30
IL227630A0	Israel	A0	2013-09-30
IL227630D0	Israel	D0	2013-09-30
IL211149A	Israel	A	2014-04-30
US8722706B2	United States of America	B2	2014-05-13
IL227630A	Israel	A	2015-02-26
CA2734119C	Canada	C	2016-01-19

4 legal events, as the office reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code
2019-07-31	Patent renewedKB	KB
2015-07-30	Patent renewedKB	KB
2014-08-31	Patent grantedGrantedFF	FF
2014-08-31	Patent renewedKB	KB